| 2001 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
53 |
| 2002 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
42 |
| 2003 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
62 |
| 2004 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
49 |
| 2005 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
61 |
| 2006 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
43 |
| 2007 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
57 |
| 2008 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
56 |
| 2009 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
55 |
| 2010 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
63 |
| 2011 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
55 |
| 2012 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
61 |
| 2013 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
47 |
| 2014 |
Bone Marrow Family |
Allogeneic |
B-Cell Precursor Acute Lymphocytic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
30 |
| 2015 |
Bone Marrow Family |
Allogeneic |
Chronic Lymphocytic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
69 |
| 2016 |
Bone Marrow Family |
Allogeneic |
Chronic Myelomonocytic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
60 |
| 2017 |
Bone Marrow Family |
Allogeneic |
Chronic Myelomonocytic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
70 |
| 2018 |
Bone Marrow Family |
Allogeneic |
Chronic Myelomonocytic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
76 |
| 2019 |
Bone Marrow Family |
Allogeneic |
Langerhans Cell Sarcoma |
Hematology |
2023 |
Standard Therapy |
Poland |
66 |
| 2020 |
Bone Marrow Family |
Allogeneic |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Poland |
63 |
| 2021 |
Bone Marrow Family |
Allogeneic |
Mycosis Fungoides |
Hematology |
2023 |
Standard Therapy |
Poland |
71 |
| 2022 |
Bone Marrow Family |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2023 |
Standard Therapy |
Poland |
71 |
| 2023 |
Bone Marrow Family |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2023 |
Standard Therapy |
Poland |
68 |
| 2024 |
Bone Marrow Family |
Allogeneic |
Myelofibrosis |
Hematology |
2023 |
Standard Therapy |
Poland |
70 |
| 2025 |
Bone Marrow Family |
Allogeneic |
No Data |
Hematology |
2023 |
Standard Therapy |
Germany |
70 |
| 2026 |
Bone Marrow Family |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2023 |
Standard Therapy |
Poland |
55 |
| 2027 |
Bone Marrow Family |
Allogeneic |
Secondary Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
73 |
| 2028 |
Bone Marrow Family |
Allogeneic |
Secondary Chronic Myelomonocytic Leukemia To Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
62 |
| 2029 |
Bone Marrow Family |
Allogeneic |
Secondary Myelodysplastic Syndrome With Excess Of Blasts |
Hematology |
2023 |
Standard Therapy |
Poland |
15 |
| 2030 |
Bone Marrow Family |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2023 |
Standard Therapy |
Poland |
71 |
| 2031 |
Bone Marrow Family |
Allogeneic |
T-Cell Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
5 |
| 2032 |
Bone Marrow |
Allogeneic |
Acute Leukemia Of Ambiguous Lineage |
Hematology |
2023 |
Standard Therapy |
Poland |
1 |
| 2033 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
11 |
| 2034 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
5 |
| 2035 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
16 |
| 2036 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
28 |
| 2037 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
14 |
| 2038 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
1 |
| 2039 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
25 |
| 2040 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
7 |
| 2041 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
4 |
| 2042 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
8 months |
| 2043 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
12 |
| 2044 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
63 |
| 2045 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
5 |
| 2046 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
12 |
| 2047 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
3 |
| 2048 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
49 |
| 2049 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
14 |
| 2050 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
47 |
| 2051 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
11 |
| 2052 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
13 |
| 2053 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
17 |
| 2054 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
32 |
| 2055 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
43 |
| 2056 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
12 |
| 2057 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
59 |
| 2058 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
38 |
| 2059 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
14 |
| 2060 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
1 |
| 2061 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
75 |
| 2062 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
55 |
| 2063 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
13 |
| 2064 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
6 |
| 2065 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
17 |
| 2066 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
34 |
| 2067 |
Bone Marrow |
Allogeneic |
Adrenoleukodystrophy |
Hematology |
2023 |
Standard Therapy |
Poland |
7 |
| 2068 |
Bone Marrow |
Allogeneic |
Adrenoleukodystrophy (Ald) – Siemerling-Creutzfeldt Disease |
Hematology |
2023 |
Standard Therapy |
Poland |
4 |
| 2069 |
Bone Marrow |
Allogeneic |
Amegakaryocytic Thrombocytopenia |
Hematology |
2023 |
Standard Therapy |
Poland |
6 months |
| 2070 |
Bone Marrow |
Allogeneic |
Anemia Fanconi |
Hematology |
2023 |
Standard Therapy |
Poland |
6 |
| 2071 |
Bone Marrow |
Allogeneic |
Aplastic Anemia |
Hematology |
2023 |
Standard Therapy |
Poland |
18 |
| 2072 |
Bone Marrow |
Allogeneic |
Aplastic Anemia |
Hematology |
2023 |
Standard Therapy |
Poland |
43 |
| 2073 |
Bone Marrow |
Allogeneic |
B-Cell Precursor Acute Lymphocytic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
12 |
| 2074 |
Bone Marrow |
Allogeneic |
Chronic Granulomatous Disease |
Hematology |
2023 |
Standard Therapy |
Poland |
12 |
| 2075 |
Bone Marrow |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
55 |
| 2076 |
Bone Marrow |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
57 |
| 2077 |
Bone Marrow |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
40 |
| 2078 |
Bone Marrow |
Allogeneic |
Chronic Myeloid Leukemia Blast Crisis |
Hematology |
2023 |
Standard Therapy |
Poland |
21 |
| 2079 |
Bone Marrow |
Allogeneic |
Clippers Syndrome |
Hematology |
2023 |
Standard Therapy |
Poland |
49 |
| 2080 |
Bone Marrow |
Allogeneic |
Congenital Amegakaryocytic Thrombocytopenia (Camt) |
Hematology |
2023 |
Standard Therapy |
Poland |
6 months |
| 2081 |
Bone Marrow |
Allogeneic |
Fanconi Anemia |
Hematology |
2023 |
Standard Therapy |
Poland |
8 |
| 2082 |
Bone Marrow |
Allogeneic |
Hemophagocytic Lymphohistiocytosis (Hlh) |
Hematology |
2023 |
Standard Therapy |
Poland |
2 |
| 2083 |
Bone Marrow |
Allogeneic |
Hodgkin’s Lymphoma |
Hematology |
2023 |
Standard Therapy |
Poland |
23 |
| 2084 |
Bone Marrow |
Allogeneic |
Immunodeficiency – Xlp1 |
Hematology |
2023 |
Standard Therapy |
Poland |
10 |
| 2085 |
Bone Marrow |
Allogeneic |
Juvenile Myelomonocytic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
5 |
| 2086 |
Bone Marrow |
Allogeneic |
Mantle Cell Lymphoma |
Hematology |
2023 |
Standard Therapy |
Poland |
68 |
| 2087 |
Bone Marrow |
Allogeneic |
Metachromatic Leukodystrophy |
Hematology |
2023 |
Standard Therapy |
Poland |
22 |
| 2088 |
Bone Marrow |
Allogeneic |
Mitochondrial Neurogastrointestinal Encephalopathy |
Hematology |
2023 |
Standard Therapy |
Poland |
33 |
| 2089 |
Bone Marrow |
Allogeneic |
Mixed Lineage Acute Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
4 |
| 2090 |
Bone Marrow |
Allogeneic |
Monocytopenia And Mycobacterial Infection (Monomac) Syndrome |
Hematology |
2023 |
Standard Therapy |
Poland |
5 |
| 2091 |
Bone Marrow |
Allogeneic |
Mucopolysaccharidosis Type I |
Hematology |
2023 |
Standard Therapy |
Poland |
2 |
| 2092 |
Bone Marrow |
Allogeneic |
Mucopolysaccharidosis Type IH (Hurler) |
Hematology |
2023 |
Standard Therapy |
Poland |
8 months |
| 2093 |
Bone Marrow |
Allogeneic |
Mucopolysaccharidosis Type Iv |
Hematology |
2023 |
Standard Therapy |
Poland |
5 |
| 2094 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2023 |
Standard Therapy |
Poland |
51 |
| 2095 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2023 |
Standard Therapy |
Poland |
11 |
| 2096 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2023 |
Standard Therapy |
Poland |
14 |
| 2097 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2023 |
Standard Therapy |
Poland |
6 |
| 2098 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2023 |
Standard Therapy |
Poland |
7 |
| 2099 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2023 |
Standard Therapy |
Poland |
19 |
| 2100 |
Bone Marrow |
Allogeneic |
No Data |
Hematology |
2023 |
Standard Therapy |
Poland |
3 |